ARTICLE | Company News
Biocoll GmbH, Genfit, University of Freiburg deal
May 16, 2011 7:00 AM UTC
The partners began the OLNORME II program to develop candidates targeting an undisclosed nuclear orphan receptor from plant metabolites to prevent and treat cardiovascular, metabolic and neurodegenera...